Factors associated with severity and exacerbation of asthma: A baseline analysis of the COhort for Reality and Evolution of adult asthma in Korea (COREA)

Annals of Allergy, Asthma and Immunology

Volumn 103, Issue 4, 2009, Pages 311-317

  Kim, Tae Bum ^a   Park, Chan Sun ^a   Bae, Yun Jeong ^a   Cho, You Sook ^a   Moon, Hee Bom ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTHMA; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOLOGY; KOREA; MALE; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SMOKING; VITAL CAPACITY;

ASTHMA; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; KOREA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING; STATISTICS, NONPARAMETRIC; VITAL CAPACITY;

EID: 77952777174     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60530-3     Document Type: Article

References (30)

1. Panhuysen CI, Vonk JM, Koeter GH, et al. Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med. 1997;155:1267-1272.
2. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax. 2003;58:322-327.
3. Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004; 92:32-39.
4. European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J. 2003;22: 470-477.
5. Gaga M, Papageorgiou N, Yiourgioti G, et al. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire. Clin Exp Allergy. 2005;35:954-959.
6. Romagnoli M, Caramori G, Braccioni F, et al. Near-fatal asthma phenotype in the ENFUMOSA Cohort. Clin Exp Allergy. 2007;37:552-557.
7. Sorkness RL, Bleecker ER, Busse WW, et al. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol. 2008;104:394-403.
8. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119:405-413.
9. Drazen JM, Lenfant C, Hurd SS. Acorns and inhalers: the Asthma Clinical Research Network. J Allergy Clin Immunol. 2007;119:28-29.
10. Clark TJH, Cagnani CB, Bousquet J. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Institutes of Health; 2002:1-176.
11. Kim TB, Kim YK, Chang YS, et al. Association between sensitization to outdoor spider mites and clinical manifestations of asthma and rhinitis in the general population of adults. J Korean Med Sci. 2006;21:247-252.
12. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143-178.
13. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics-2002. J Allergy Clin Immunol. 2002;110:S141-219.
14. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE. Severity assessment in asthma: an evolving concept. J Allergy Clin Immunol. 2005;116:990-995.
15. Mosen DM, Schatz M, Magid DJ, Camargo CA Jr. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol. 2008;122:507-511.
16. Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med. 2006;100:648-657.
17. Sears MR. Consequences of long-term inflammation: the natural history of asthma. Clin Chest Med. 2000;21:315-329.
18. Descatha A, Leproust H, Choudat D, Garnier R, Pairon JC, Ameille J. Factors associated with severity of occupational asthma with a latency period at diagnosis. Allergy. 2007;62:795-801.
19. Jenkins HA, Cherniack R, Szefler SJ, Covar R, Gelfand EW, Spahn JD. A comparison of the clinical characteristics of children and adults with severe asthma. Chest. 2003;124:1318-1324.
20. Cassino C, Berger KI, Goldring RM, et al. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med. 2000;162:1423-1428.
21. ten Brinke A. Risk factors associated with irreversible airflow limitation in asthma. Curr Opin Allergy Clin Immunol. 2008;8:63-69.
22. Althuis MD, Sexton M, Prybylski D. Cigarette smoking and asthma symptom severity among adult asthmatics. J Asthma. 1999;36:257-264.
23. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339:1194-1200.
24. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study: epidemiological study on the genetics and environment of asthma. Eur Respir J. 2000;15:470-477.
25. Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1,075 outpatients with asthma. Chest. 1995;108:10-15.
26. Hylkema MN, Sterk PJ, de Boer WI, Postma DS. Tobacco use in relation to COPD and asthma. Eur Respir J. 2007;29:438-445.
27. Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007;101:481-489.
28. Sullivan SD, Wenzel SE, Bresnahan BW, et al. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy. 2007;62:655-660.
29. Covar RA, Szefler SJ, Zeiger RS, et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol. 2008;122:741-747 e744.
30. Miller TP, Oswald FL, Reeves MJ. An exploration of factors underlying asthma care and morbidity: a factor analysis of clinical variables. J Allergy Clin Immunol. 2008;122:328-334.